These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 30613000

  • 41. Real-world outcomes for a digital prescription mobile application for adults with irritable bowel syndrome.
    Pathipati MP, Scott LL, Griser AC, Staller K.
    Neurogastroenterol Motil; 2024 Jul; 36(7):e14811. PubMed ID: 38689434
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Biofeedback for treatment of irritable bowel syndrome.
    Goldenberg JZ, Brignall M, Hamilton M, Beardsley J, Batson RD, Hawrelak J, Lichtenstein B, Johnston BC.
    Cochrane Database Syst Rev; 2019 Nov 12; 2019(11):. PubMed ID: 31713856
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
    Pinto-Sanchez MI, Hall GB, Ghajar K, Nardelli A, Bolino C, Lau JT, Martin FP, Cominetti O, Welsh C, Rieder A, Traynor J, Gregory C, De Palma G, Pigrau M, Ford AC, Macri J, Berger B, Bergonzelli G, Surette MG, Collins SM, Moayyedi P, Bercik P.
    Gastroenterology; 2017 Aug 12; 153(2):448-459.e8. PubMed ID: 28483500
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Management of irritable bowel syndrome in primary care: feasibility randomised controlled trial of mebeverine, methylcellulose, placebo and a patient self-management cognitive behavioural therapy website. (MIBS trial).
    Everitt HA, Moss-Morris RE, Sibelli A, Tapp L, Coleman NS, Yardley L, Smith PW, Little PS.
    BMC Gastroenterol; 2010 Nov 18; 10():136. PubMed ID: 21087463
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Exploring patients' views of a cognitive behavioral therapy-based website for the self-management of irritable bowel syndrome symptoms.
    Tonkin-Crine S, Bishop FL, Ellis M, Moss-Morris R, Everitt H.
    J Med Internet Res; 2013 Sep 03; 15(9):e190. PubMed ID: 24001787
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
    Lindfors P, Ljótsson B, Bjornsson E, Abrahamsson H, Simrén M.
    Neurogastroenterol Motil; 2013 Feb 03; 25(2):169-e86. PubMed ID: 23051178
    [Abstract] [Full Text] [Related]

  • 57. Psychosocial predictors of self-reported fatigue in patients with moderate to severe irritable bowel syndrome.
    Lackner JM, Gudleski GD, Dimuro J, Keefer L, Brenner DM.
    Behav Res Ther; 2013 Jun 03; 51(6):323-31. PubMed ID: 23578499
    [Abstract] [Full Text] [Related]

  • 58. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial.
    Gaylord SA, Palsson OS, Garland EL, Faurot KR, Coble RS, Mann JD, Frey W, Leniek K, Whitehead WE.
    Am J Gastroenterol; 2011 Sep 03; 106(9):1678-88. PubMed ID: 21691341
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.